Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' / Šufliarsky J. ... [et al.].
In: Onkológia. -- ISSN 1336-8176. -- Roč. 13, č. 3 (2018), s. 222.
sarkóm svetlobunkový - farmakoterapia * krizotinib